Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review.
about
Biomarkers of progression of chronic obstructive pulmonary disease (COPD)Biomarkers for pediatric pulmonary arterial hypertension - a call to collaborateBreath analysis as a potential and non-invasive frontier in disease diagnosis: an overviewAdvances in electronic-nose technologies for the detection of volatile biomarker metabolites in the human breath.Exhaled breath profiling for diagnosing acute respiratory distress syndrome.Lung Cancer Screening Based on Type-different Sensor Arrays.Exhaled breath analysis for the early detection of lung cancer: recent developments and future prospects.Expiratory flow rate, breath hold and anatomic dead space influence electronic nose ability to detect lung cancer.Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects.Single-carbon discrimination by selected peptides for individual detection of volatile organic compoundsCannabinoids in exhaled breath following controlled administration of smoked cannabis.BreathDx - molecular analysis of exhaled breath as a diagnostic test for ventilator-associated pneumonia: protocol for a European multicentre observational study.Trends in Nanomaterial-Based Non-Invasive Diabetes Sensing TechnologiesClinical contributions of exhaled volatile organic compounds in the diagnosis of lung cancerSpecial considerations for the diagnosis and treatment of invasive pulmonary aspergillosis.Evaluation of Chemical Interactions between Small Molecules in the Gas Phase Using Chemical Force Microscopy.Development of an Exhaled Breath Monitoring System with Semiconductive Gas Sensors, a Gas Condenser Unit, and Gas Chromatograph ColumnsNanostructured Polypyrrole-Based Ammonia and Volatile Organic Compound SensorsNoninvasive analysis of volatile biomarkers in human emanations for health and early disease diagnosis.Will symptom-based therapy be effective for treating asthma in children?Challenges of COPD diagnosis.Toward composite molecular signatures in the phenotyping of asthma.Lung cancer screening beyond low-dose computed tomography: the role of novel biomarkers.Biomarkers to predict asthma in wheezing preschool children.Exhaled breath analysis by electronic nose in respiratory diseases.Gas-phase broadband spectroscopy using active sources: progress, status, and applications.Pattern recognition for predictive, preventive, and personalized medicine in cancer.Improving the diagnosis of eosinophilic asthma.Inflammatory bowel disease and patterns of volatile organic compounds in the exhaled breath of children: A case-control study using Ion Molecule Reaction-Mass Spectrometry.Fusing Sensor Paradigms to Acquire Chemical Information: An Integrative Role for Smart Biopolymeric Hydrogels.Screening of Obstructive Sleep Apnea Syndrome by Electronic-Nose Analysis of Volatile Organic CompoundsMetabolomics for the masses: The future of metabolomics in a personalized world.Rational lung tissue and animal models for rapid breath tests to determine pneumonia and pathogens.Modulation of population density and size of silver nanoparticles embedded in bacterial cellulose via ammonia exposure: visual detection of volatile compounds in a piece of plasmonic nanopaper.Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review.Answer to: "Biomarkers in allergic asthma: Which matrix should we use?"Exhaled biomarkers and gene expression at preschool age improve asthma prediction at 6 years of age.Combined sputum hypermethylation and eNose analysis for lung cancer diagnosis.A Linear-Quadratic Model for the Quantification of a Mixture of Two Diluted Gases with a Single Metal Oxide Sensor.The Smell of Hypoxia: using an electronic nose at altitude and proof of concept of its role in the prediction and diagnosis of acute mountain sickness
P2860
Q26996356-90A2968C-2AAA-4566-B57B-09D71C477D66Q27026465-6A2BD57D-6137-447B-9D85-B46257C6DD2BQ28085084-DAB07046-65E0-43D8-BD77-66240CF04E4BQ29109861-8C6A0059-8F0A-4A7A-9D6F-A97181B74879Q33613793-8B2993CD-01CA-4F72-8CD1-01D7580EBB43Q33694726-977550DE-D03F-41DC-99C6-6EA8906F7D10Q33713144-E3D4A377-3B70-4278-8B2B-143F6746823AQ34901092-1237EFCA-1AA2-4F4A-B1F8-2035E2D388B0Q35136150-027F8629-5E20-4163-85F6-4B2BA50FF007Q35579123-91C97BD5-17CF-4B7A-9FDD-31E3C7025E02Q35956968-7EE16DA4-160C-42CB-9763-0A36C0FF4F11Q36238880-FB3FB241-3CD2-42E0-9A5A-1A9D253234AEQ36335181-41D4F8E8-F995-4C83-93B4-8BD49CD30217Q36338437-6AF4CD8E-5433-4EE7-BA7A-0B28CF8DF19DQ36396166-E07FD156-5A4F-4F34-B716-797057C21B99Q36487489-53F40789-D966-4E62-B1D8-7E5082E17C07Q37467282-1DC5C1FA-2C98-4129-9466-FF6A388842F3Q37732687-5F4CFCCF-CEE5-4FA2-8519-35532512E85CQ38112480-5F8F0932-C772-4905-B8F5-C16BCD19293CQ38115172-508C9D0D-4F3A-4F33-9544-E253D1953859Q38149946-D69A5431-53DC-4A5F-A808-2CAFB9C4F6C8Q38169244-DAE25FD3-B103-4242-8E6C-42797E8600D1Q38238438-E81350AB-02F0-4F11-AC3E-2BF7C79341C4Q38269552-63E5873B-2CEC-4E7B-A500-702F55EAE41CQ38470325-E625C08A-EC58-4513-9935-7A821C488066Q38669152-EF5105E9-8632-4C40-95CB-C0CE53943F9AQ38670423-7072FA31-88C5-4C1C-95CF-3DB4E70F706EQ38821540-7214186D-0056-4FFA-B52E-10DBD784AB63Q41577330-B8AEA501-B33E-4D20-939F-28DA0FFE1308Q41628681-31115A6D-AC57-41BA-A8BB-A1FC4A5BB2BAQ41696879-09B67091-CC84-416F-A146-8105B32C97C0Q44951888-3332D916-0503-492B-922E-D58E2C9E30B5Q46127852-B1DCD884-4DD3-4B86-87EE-D889AE25B0C1Q47316021-1242BC56-71DD-4911-B062-05535DEDBBE2Q47735253-50997B91-EA33-4C03-880D-0290B813817DQ48238507-A340AA62-863C-4530-B449-41ADC4FE1CC1Q51677457-8E110A7B-4BEA-4525-98FB-39B37C3769D3Q51717884-0C1F4B8D-B0EE-40A0-9716-3B6720009579Q55497588-95DA05DF-559D-41B3-9AC8-D7EEF8452134Q57091722-E05AB427-2DA1-47BD-9191-203AAC6A391C
P2860
Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Clinical use of exhaled volati ...... diseases: a systematic review.
@ast
Clinical use of exhaled volati ...... diseases: a systematic review.
@en
type
label
Clinical use of exhaled volati ...... diseases: a systematic review.
@ast
Clinical use of exhaled volati ...... diseases: a systematic review.
@en
prefLabel
Clinical use of exhaled volati ...... diseases: a systematic review.
@ast
Clinical use of exhaled volati ...... diseases: a systematic review.
@en
P2093
P2860
P31
P356
P1433
P1476
Clinical use of exhaled volati ...... diseases: a systematic review.
@en
P2093
Edward Dompeling
Kim D G van de Kant
Linda J T M van der Sande
Onno C P van Schayck
Quirijn Jöbsis
P2860
P2888
P356
10.1186/1465-9921-13-117
P5008
P577
2012-12-21T00:00:00Z
P5875
P6179
1000852654